Analysis of the Dynamics of a Tumor–Immune System with Chemotherapy and Immunotherapy and Quadratic Optimal Control

被引：38

作者：

Sharma S. ^{[1
]}

Samanta G.P. ^{[1
]}

机构：

[1] Department of Mathematics, Indian Institute of Engineering Science and Technology, Shibpur, Howrah

来源：

Differential Equations and Dynamical Systems | 2016年 / 24卷 / 2期

关键词：

Chemotherapeutic drug; Immunotherapeutic drug; Optimal control; Stability; Tumor growth model;

D O I：

10.1007/s12591-015-0250-1

中图分类号：

学科分类号：

摘要：

In this paper, we consider a tumor growth model with the effect of tumor–immune interactions and chemotherapeutic as well as immunotherapeutic drugs. In our model there are four compartments, namely tumor cells, immune cells, chemotherapeutic drug concentration and immunotherapeutic drug concentration. The dynamical behaviour of our system by analyzing the existence and stability of our system at various equilibria is discussed elaborately. We set up an optimal control problem relative to the model so as to minimize the number of tumor cells and the chemotherapeutic and immunotherapeutic drugs administration. Here we use a quadratic control to quantify this goal and consider the administration of chemotherapy and immunotherapeutic drugs as controls to reduce the spread of the tumor growth. The important mathematical findings for the dynamical behaviour of the tumor–immune model are also numerically verified using MATLAB. Finally epidemiological implications of our analytical findings are addressed critically. © 2015, Foundation for Scientific Research and Technological Innovation.

引用

页码：149 / 171

页数：22

共 41 条

[11]

de Pillis L.G., Radunskaya A.E., Wiseman C.L., A validatted mathematical model of cell-mediated immune response to tumor growth, Cancer Res., 61, 17, (2005)

[12]

Derbel L., Analysis of a new model for tumor-immune system competition including long time scale effects, Math. Model Methods Appl. Sci., 14, (2004)

[13]

Diefenbach A., Jensen E.R., Jamieson A.M., Raulet D., Real and H60 ligands of the NKG2D receptor stimulate tumor immunity, Nature, 413, (2001)

[14]

d'Onofrio A., A general framework for modeling tumor-immune system competition and immunotherapy: mathematical analysis and biomedical references, Physica D, 208, (2005)

[15]

Engelhart M., Lebiedz D., Sager S., Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function, Math. Biosci., 229, pp. 123-134, (2011)

[16]

Fister K.R., Donnelly J., Immunotherapy: an optimal control theory approach, Math. Biosci. Eng., 2, 3, (2005)

[17]

Fister K.R., Panetta J.C., Optimal control applied to cell-cycle specific cancer chemotherapy, SIAM J. Appl. Math., 60, 3, (2000)

[18]

Fister K.R., Panetta J.C., Optimal control applied to competing chemotherapeutic cell-kill strategies, SIAM J. Appl. Math., 63, 6, (2003)

[19]

Fleming W.H., Rishel R.W., Deterministic and Stochastic Optimal Control, (1975)

[20]

Hale J.K., Theory of Functional Differential Equations, (1977)

← 1 2 3 4 5 →